Pediatrix Medical Group (MD) PT Raised to $10 at Truist Securities

Truist Securities analyst David MacDonald raised the price target on Pediatrix Medical Group (NYSE: MD) to $10.00 (from $8.00) while maintaining a Hold rating.

The analyst commented: "We have adjusted our estimates to reflect 2Q results, raising our 2024E and 2025E adjusted EBITDA to $208.2M and $218.0M (vs. prior $201.1M and $208.0M, respectively). We maintain our Hold rating and are raising our price target to $10 (vs. prior $8)."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Boeing lands two U.S. defense contracts worth over $711M
• Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating